These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 21478824)
1. Expression of FOXL2 in human normal pituitaries and pituitary adenomas. Egashira N; Takekoshi S; Takei M; Teramoto A; Osamura RY Mod Pathol; 2011 Jun; 24(6):765-73. PubMed ID: 21478824 [TBL] [Abstract][Full Text] [Related]
2. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas. Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163 [TBL] [Abstract][Full Text] [Related]
4. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Oyama K; Sanno N; Teramoto A; Osamura RY Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas. Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002 [TBL] [Abstract][Full Text] [Related]
6. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method. Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563 [TBL] [Abstract][Full Text] [Related]
8. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702 [TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839 [TBL] [Abstract][Full Text] [Related]
10. Leptin and the pituitary. Sone M; Osamura RY Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504 [TBL] [Abstract][Full Text] [Related]
11. Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization. Oka H; Kameya T; Sato Y; Naritaka H; Kawano N J Neurooncol; 1999 Feb; 41(3):197-204. PubMed ID: 10359139 [TBL] [Abstract][Full Text] [Related]
12. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture. Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1. Sanno N; Itoh J; Teramoto A; Itoh Y; Hori S; Osamura RY J Neurooncol; 1997 Oct; 35(1):29-38. PubMed ID: 9266438 [TBL] [Abstract][Full Text] [Related]
14. Expression of MSX1 in human normal pituitaries and pituitary adenomas. Mizokami Y; Egashira N; Takekoshi S; Itoh J; Itoh Y; Osamura RY; Matsumae M Endocr Pathol; 2008; 19(1):54-61. PubMed ID: 18379900 [TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [TBL] [Abstract][Full Text] [Related]
16. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110 [TBL] [Abstract][Full Text] [Related]
17. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H; Saeger W Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies on human pituitary gland and adenomas. Kasper M; Kasper M; Kern F; Heitz PU; Gudat F J Hirnforsch; 1991; 32(6):725-34. PubMed ID: 1821419 [TBL] [Abstract][Full Text] [Related]
19. Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors. Ishii Y; Suzuki M; Takekoshi S; Egashira N; Yamazaki M; Miyai S; Sanno N; Teramoto A; Osamura RY Endocr Pathol; 2006; 17(1):35-43. PubMed ID: 16760578 [TBL] [Abstract][Full Text] [Related]